HMGB3 and cervical cancer: In the present paper we identified six putative biomarkers (AURKA, DTL, HMGB3, KIF2C, NEK2, and RFC4) which should be further tested to separate indolent HPV related cervical infections from progressive CIN III lesions and for early diagnosis of cervical cancer.